[1]
“Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system”, Braz. J. Pharm. Sci., vol. 53, no. 3, p. e00178-, Jan. 2017, doi: 10.1590/s2175-97902017000300178.